Johns Hopkins University School of Medicine Neuroprotective drug may be possible NAION therapy February 15, 2017 By Vanessa Caceres Non-arteritic ischemic optic neuropathy can be difficult to treat. A new drug under investigation aims to prevent further loss of vision from the condition. Tracking treatment adherence in newly diagnosed open-angle glaucoma January 01, 2017 By Lynda Charters An analysis of U.S. claims data reveals a substantial proportion of patients (17%) remained untreated 4 years after their initial diagnosis of open-angle glaucoma. Exploring ocular demodicosis in chronic blepharitis By knowing the signs and symptoms of Demodex, ophthalmologists can better diagnose and offer treatments for blepharitis. When old, new technologies converge for dry eye diagnosis March 15, 2016 Physicians should take a multipronged approach to dry eye disease, especially in its diagnosis, advises David B. Glasser, MD. ‘Super formula’ maximizes accuracy for IOL powers February 01, 2016 By Lynda Charters An IOL “super formula” may broaden the conceptual understanding of IOL calculations, improve clinical outcomes for patients, and stimulate further progress in IOL formula research. Artificial cornea may be alternative to repeat PK in certain patients September 01, 2015 By Esen K. Akpek MD Findings of a retrospective case review show that eyes that underwent implantation of the Boston Type 1 keratoprosthesis had greater improvement in visual acuity than those undergoing repeat donor corneal transplantation. Novel modalities expand glaucoma therapeutic arsenal Active research in neuroprotection, neuroregeneration, and sustained drug delivery is expected to lead to better options for management of glaucoma. Nanotechnology suitable match for treatment of eye disease Collaborations with practicing ophthalmologists have been crucial to nanotechnology discoveries pertaining to eye diseases, and in which drug can be delivered to the eye. How laser cataract surgery stacks up against conventional phaco Today’s laser cataract surgery is outperforming the early days of phacoemulsification and may outperform current phacoemulsification technology in the next few years, explained Yassine Daoud, MD, in a dialogue about the technology. Inverted Brown pattern may warrant inferior oblique weakening procedure In cases of an inverted Brown pattern, a large inferior oblique weakening procedure may be the first procedure to perform—even though the inferior oblique muscle is not significantly overacting.